European journal of neurology · 2025
Variably Defined Conduction Block, Temporal Dispersion and Other Electrophysiological Abnormalities in Multifocal Motor Neuropathy: A Multicentre Study.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rajabally Yusuf A, Min Young Gi, Al-Areed Ahmad, Ju Woohee, Arunachalam Ramamurthy, Sung Jung-Joon, Osman Chinar
Аннотация
BACKGROUND: The definition of conduction block (CB) is variable in multifocal motor neuropathy (MMN). In current criteria, excessive temporal dispersion (TD) may preclude the recognition of CB and the diagnosis of MMN.
METHODS: We retrospectively studied the electrophysiological data of 47 consecutive subjects with MMN and of 69 consecutive controls with upper limb-onset motor neuron disease, from three neuromuscular centres in the United Kingdom and Korea.
RESULTS: Compared to CB defined by compound muscle action potential (CMAP) area reduction (CB-Area) > 30%, CB defined by CMAP amplitude reduction (CB-amp) > 30% was more sensitive (78.7% vs. 63.8%; McNemar's Test: p = 0.008), but less specific versus controls (90.1% vs. 96.7%; McNemar's Test: p = 0.001). CB-amp > 30% offered greater diagnostic accuracy than CB-Area > 30% (Youden's Index: 0.688 vs. 0.606). TD showed a sensitivity of 59.6% and specificity of 94.3%. F-wave prolongation or absence showed a sensitivity of 42.6% and specificity of 96.9%. Considering CB-amp > 30% or TD or F-wave prolongation or absence, as independent electrodiagnostic markers of MMN, improved diagnostic sensitivity from 78.7% to 91.5% compared to CB-amp > 30% alone (McNemar's Test: p = 0.031), also offering optimal accuracy (Youden's Index: 0.816). Within this three-parameter combination, CB defined by CMAP amplitude reduction > 30% offered similar sensitivity, specificity and accuracy to when defined by CMAP amplitude reduction > 50%.
CONCLUSIONS: CB-amp has higher sensitivity and accuracy than CB-Area for the electrodiagnosis of MMN. Consideration of TD or F-wave prolongation or absence, as independently diagnostic of MMN, in addition to CB-amp > 30% alone, may improve electrophysiological sensitivity as well as accuracy.
METHODS: We retrospectively studied the electrophysiological data of 47 consecutive subjects with MMN and of 69 consecutive controls with upper limb-onset motor neuron disease, from three neuromuscular centres in the United Kingdom and Korea.
RESULTS: Compared to CB defined by compound muscle action potential (CMAP) area reduction (CB-Area) > 30%, CB defined by CMAP amplitude reduction (CB-amp) > 30% was more sensitive (78.7% vs. 63.8%; McNemar's Test: p = 0.008), but less specific versus controls (90.1% vs. 96.7%; McNemar's Test: p = 0.001). CB-amp > 30% offered greater diagnostic accuracy than CB-Area > 30% (Youden's Index: 0.688 vs. 0.606). TD showed a sensitivity of 59.6% and specificity of 94.3%. F-wave prolongation or absence showed a sensitivity of 42.6% and specificity of 96.9%. Considering CB-amp > 30% or TD or F-wave prolongation or absence, as independent electrodiagnostic markers of MMN, improved diagnostic sensitivity from 78.7% to 91.5% compared to CB-amp > 30% alone (McNemar's Test: p = 0.031), also offering optimal accuracy (Youden's Index: 0.816). Within this three-parameter combination, CB defined by CMAP amplitude reduction > 30% offered similar sensitivity, specificity and accuracy to when defined by CMAP amplitude reduction > 50%.
CONCLUSIONS: CB-amp has higher sensitivity and accuracy than CB-Area for the electrodiagnosis of MMN. Consideration of TD or F-wave prolongation or absence, as independently diagnostic of MMN, in addition to CB-amp > 30% alone, may improve electrophysiological sensitivity as well as accuracy.